Investigators assessed which factors contribute to risk for GI-related hospitalizations in infants with cystic fibrosis.
Can an intervention approach emphasizing habit formation improve treatment adherence and outcomes for patients with cystic fibrosis?
The researchers sought to identify predictors of disease progression and mortality in non-IPF fILD using criteria from the INBUILD, RELIEF, and uILD trials.
A clinical trial disproved the notion that adding cyclophosphamide pulses to glucocorticoids was effective for acute exacerbation of IPF.
A clinical trial showed ELX-TEZ-IVA had benefits over other CFTR modulators for patients with Phe508del-gating or Phe508del-residual function genotypes.
Investigators found that aging and bronchiolitis obliterans syndrome are both associated with increased interalveolar communications.
This studied focused on primary prescription adherence for obstructive lung diseases among adult patients in primary care over a 3-year period.
The approval was based on data from a phase 3 study that evaluated Trikafta in 66 children 6 to 11 years of age with CF who were either homozygous for the F508del mutation or heterozygous for the F508del mutation and 1 minimal function mutation.